Evaluation of monophosphoryl lipid A as a vaccine adjuvant for a multivalent pneumococcal glycoconjugate vaccine in mice.

被引：0
作者：
Dermody, KM [1 ]
Mason, KW [1 ]
La Posta, VJ [1 ]
机构：
[1] Lederle Vaccines & Pediat, W Henrietta, NY 14586 USA
来源：
FASEB JOURNAL | 1998年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
3557
引用
收藏
页码：A612 / A612
页数：1
相关论文
共 50 条
  • [41] Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial
    Simon, Michael W.
    Bataille, Regine
    Caldwell, Nicole S.
    Gessner, Bradford D.
    Jodar, Luis
    Lamberth, Erik
    Peng, Yahong
    Scott, Daniel A.
    Lei, Lanyu
    Giardina, Peter C.
    Gruber, William C.
    Jansen, Kathrin U.
    Thompson, Allison
    Watson, Wendy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [42] Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine
    Neimert-Andersson, Theresa
    Hallgren, Anne-Charlotte
    Andersson, Mats
    Langeback, Joakim
    Zettergren, Louise
    Nilsen-Nygaard, Julie
    Draget, Kurt Ingar
    van Hage, Marianne
    Lindberg, Alf
    Gafvelin, Guro
    Gronlund, Hans
    VACCINE, 2011, 29 (48) : 8965 - 8973
  • [43] Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL®) adjuvant:: a new allergy vaccine for dust mite allergy
    Baldrick, P
    Richardson, D
    Wheeler, AW
    VACCINE, 2001, 20 (5-6) : 737 - 743
  • [44] Maintained partial protection against Streptococcus pneumoniae despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine
    Ercoli, Giuseppe
    Ramos-Sevillano, Elisa
    Pearce, Emma
    Ragab, Sara
    Goldblatt, David
    Weckbecker, Gisbert
    Brown, Jeremy S.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (01)
  • [45] New pneumococcal vaccine elicits wide protection in mice
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (12) : 2753 - 2753
  • [46] A clinically applicable adjuvant for an atherosclerosis vaccine in mice
    Kobiyama, Kouji
    Vassallo, Melanie
    Mitzi, Jessica
    Winkels, Holger
    Pei, Hong
    Kimura, Takayuki
    Miller, Jacqueline
    Wolf, Dennis
    Ley, Klaus
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (09) : 1580 - 1587
  • [47] ENHANCEMENT OF INFLUENZA-A VIRUS PROTECTIVE IMMUNITY IN MICE USING MONOPHOSPHORYL LIPID-A AND TREHALOSE DIMYCOLATE AS VACCINE ADJUVANTS
    ULRICH, I
    WELTY, D
    FASEB JOURNAL, 1988, 2 (04) : A832 - A832
  • [48] Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs
    Jinyong Zhang
    Peng Wang
    Zhuoxin Li
    Yubiao Xie
    Ningyi Jin
    He Zhang
    Huijun Lu
    Jicheng Han
    BMC Veterinary Research, 20
  • [49] Development of a TERT-specific peptide/adjuvant vaccine in C57BL/6 mice.
    Marshall, Jason D.
    Song, Yurong
    Zarkesh, Hamid
    Matthews, Rebecca L.
    Sanders, Chelsea
    Difilippantonio, Simone
    Pinto, Ligia A.
    Sei, Shizuko
    Shoemaker, Robert H.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] A multivalent vaccine does not accelerate the onset of diabetes in NOD mice
    Stone, V. M.
    Butrym, M.
    Hankaniemi, M. M.
    Sioofy-Khojine, A. -B.
    Hytonen, V. P.
    Hyoty, H.
    Flodstrom-Tullberg, M.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 155 - 156
12345